New Drug Doubles Survival for Pancreatic Cancer Patients

A new drug has shown a significant breakthrough in treating pancreatic cancer. Patients with the disease in its advanced stages experienced a doubling of their survival rates compared to those receiving standard chemotherapy. This represents a major advancement for these particularly aggressive tumors.

Summarized from the sources above. Read the originals for the full story.